Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Applied Genetic Technologies, Airway, Assertio, Cansino, Celonic, Coda, Faron, Hoth, Inovio, Iqvia, Kindred, Nanoviricides, Merck, Precision Macrosystems, Surface, Vaxart, Zyla.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alkermes, Arch, Astex, Beyond Air, Cidara, Cyclo, Diffusion, Forma, KBP, Roche, Santhera.

Biopharmas raising money in public or private financings, including: ADC, Akebia, Biomarin, Biondvax, Biosig, Diffusion, Idorsia, Octant, Ocular, Oncternal, Oyster Point, Silence, Strongbridge, Surface Oncology, Tricida, Windtree, Xbrane.

New hires and promotions in the biopharma industry, including: Alivamab, Galecto, Gibson.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Abivax, Astellas, Bone, Glenmark, I-Mab, JHL, Kaleido, Moderna, Neurorx, Oryzon Genomics, Relief, Roivant Sciences, Samsung Bioepis, Taiwan Liposome, Zai Lab.

Biopharmas in Asia-Pacific raising money in public or private financings, including: Abivax, Apeiron, Greenlight, Hemogenyx, Modulus Discovery, Peptidream, Travecta.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Acer, Akers, Avacta, Bonus Biogroup, Cansino, Cellect, Cipla, Citius, Cmab, Creoptix, Curevac, Cytoagents, E-therapeutics, Exvastat, Gilead, Glaxosmithkline, Gryt, Iksuda, Immunovative, Jubilant, Legend Biotech, Legochem, Lengo, Luye, Manhattan Biosolutions, Medicago, Mercaptor Discoveries, Mirror, Moksha8, Mylan, Mymetics, Nanoviricides, Nascent, Novellus, Orgenesis, Patrys, Pluristem, Predictive Oncology, Premas, Primary Peptides, Promis, Qurebio, Recursion, Simcere, Sorrento, Syntekabio, Takeda, Teva, Transgene, Vir, Viralclear, Vsy, Wize, Wuxi, Yumab.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Abivax, Aim Immunotech, Akebia, Algernon, Ascletis, Astrazeneca, Biosig Technologies, Can-Fite, Carsgen, Cytodyn, Daiichi Sankyo, Enzychem Lifesciences, Immunic, Kancera, Leading Biosciences, Moderna, Nantkwest, Novocure, Pharmazz, Restem, Scimount, Seattle Genetics, Takeda, Teva, Vistagen, Zai Lab.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Archerdx, Bio-Rad, Cochlear, Invivoscribe, Ortho, Quidel, Theradiag, Thermedical.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 10x Genomics, 20/20 Genesystems, AACC, Adaptas Solutions, Avero Diagnostics, Biodesix, Curative, Diaceutics, Diethelmkellersiberhegner, ERT, Flatiron Health, Foundation Medicine, Froedtert, Genentech, Inovalon, Korvalabs, L3harris, Oxford Immunotec Global, Partitalia, Physitrack, Roche, Royal Philips, Rewalk Robotics, Sensor ID, Shanghai Biotechnology Devices, Translational Genomics Institute, Ubiquitome, Viraxclear, Zenitas Healthcare.